Offerings of common stock and depositary shares previously announced by Becton Dickinson are now expected to pull in $4.95 billion after the underwriters' overallotment options have been exercised, with underwriters purchasing $225 million for additional common stock and $225 million for additional depositary shares. The proceeds will be used to partly fund the company's $24 billion acquisition of C.R. Bard.
Options exercise brings total proceeds from BD's offerings to $4.95B
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.